APO Research
Talk to an analyst

APO RESEARCH · REPORT

Arthritis Drug

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Arthritis Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025183 pages

Choose your research edition.

Industry ResearchArthritis Drug Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Arthritis Drug Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Arthritis Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Arthritis Drug Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Arthritis Drug Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Arthritis Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Arthritis Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Arthritis Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Arthritis Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Arthritis Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Arthritis Drug include Celltrion, F. Hoffmann-La Roche, GSK, Pfizer, Eli Lilly, Novartis and Johnson & Johnson, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Arthritis Drug market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Arthritis Drug and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Arthritis Drug sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Arthritis Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Arthritis Drug Segment by Company

Celltrion

F. Hoffmann-La Roche

GSK

Pfizer

Eli Lilly

Novartis

Johnson & Johnson

Arthritis Drug Segment by Type

Analgesics

Biological DMARDs

Corticosteroids

Synthetic DMARDs

NSAIDs

Arthritis Drug Segment by Application

Hospital Pharmacies

Drug Stores

Retail Pharmacies

E-Commerce

Arthritis Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Arthritis Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Arthritis Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Arthritis Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Arthritis Drug market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Arthritis Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Arthritis Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Arthritis Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Arthritis Drug Industry Trends Table 2. Arthritis Drug Industry Drivers Table 3. Arthritis Drug Industry Opportunities and Challenges Table 4. Arthritis Drug Industry Restraints Table 5. Global Arthritis Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Arthritis Drug Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Arthritis Drug Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Arthritis Drug Sales Market Share by Manufacturers Table 9. Global Arthritis Drug Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Arthritis Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Arthritis Drug Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Arthritis Drug Manufacturers, Product Type & Application Table 13. Global Arthritis Drug Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Arthritis Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Analgesics Table 17. Major Manufacturers of Biological DMARDs Table 18. Major Manufacturers of Corticosteroids Table 19. Major Manufacturers of Synthetic DMARDs Table 20. Major Manufacturers of NSAIDs Table 21. Global Arthritis Drug Sales by Type 2021 VS 2025 VS 2032 (k units) Table 22. Global Arthritis Drug Sales by Type (2021-2026) & (k units) Table 23. Global Arthritis Drug Sales by Type (2027-2032) & (k units) Table 24. Global Arthritis Drug Sales Market Share by Type (2021-2026) Table 25. Global Arthritis Drug Sales Market Share by Type (2027-2032) Table 26. Global Arthritis Drug Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 27. Global Arthritis Drug Revenue by Type (2021-2026) & (k units) Table 28. Global Arthritis Drug Revenue by Type (2027-2032) & (k units) Table 29. Global Arthritis Drug Revenue Market Share by Type (2021-2026) Table 30. Global Arthritis Drug Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Hospital Pharmacies Table 32. Major Manufacturers of Drug Stores Table 33. Major Manufacturers of Retail Pharmacies Table 34. Major Manufacturers of E-Commerce Table 35. Global Arthritis Drug Sales by Application 2021 VS 2025 VS 2032 (k units) Table 36. Global Arthritis Drug Sales by Application (2021-2026) & (k units) Table 37. Global Arthritis Drug Sales by Application (2027-2032) & (k units) Table 38. Global Arthritis Drug Sales Market Share by Application (2021-2026) Table 39. Global Arthritis Drug Sales Market Share by Application (2027-2032) Table 40. Global Arthritis Drug Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 41. Global Arthritis Drug Revenue by Application (2021-2026) & (k units) Table 42. Global Arthritis Drug Revenue by Application (2027-2032) & (k units) Table 43. Global Arthritis Drug Revenue Market Share by Application (2021-2026) Table 44. Global Arthritis Drug Revenue Market Share by Application (2027-2032) Table 45. Global Arthritis Drug Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 46. Global Arthritis Drug Sales by Region (2021-2026) & (k units) Table 47. Global Arthritis Drug Sales Market Share by Region (2021-2026) Table 48. Global Arthritis Drug Sales Forecasted by Region (2027-2032) & (k units) Table 49. Global Arthritis Drug Sales Forecasted Market Share by Region (2027-2032) Table 50. North America Arthritis Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 51. North America Arthritis Drug Sales by Country (2021-2026) & (k units) Table 52. North America Arthritis Drug Sales by Country (2027-2032) & (k units) Table 53. Europe Arthritis Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 54. Europe Arthritis Drug Sales by Country (2021-2026) & (k units) Table 55. Europe Arthritis Drug Sales by Country (2027-2032) & (k units) Table 56. Asia Pacific Arthritis Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 57. Asia Pacific Arthritis Drug Sales by Country (2021-2026) & (k units) Table 58. Asia Pacific Arthritis Drug Sales by Country (2027-2032) & (k units) Table 59. South America, Middle East and Africa Arthritis Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 60. South America, Middle East and Africa Arthritis Drug Sales by Country (2021-2026) & (k units) Table 61. South America, Middle East and Africa Arthritis Drug Sales by Country (2027-2032) & (k units) Table 62. Global Arthritis Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 63. Global Arthritis Drug Revenue by Region (2021-2026) & (US$ Million) Table 64. Global Arthritis Drug Revenue by Region (2027-2032) & (US$ Million) Table 65. Global Arthritis Drug Revenue Market Share by Region (2021-2026) Table 66. Global Arthritis Drug Revenue Market Share by Region (2027-2032) Table 67. Celltrion Company Information Table 68. Celltrion Business Overview Table 69. Celltrion Arthritis Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Celltrion Arthritis Drug Product Portfolio Table 71. Celltrion Recent Development Table 72. F. Hoffmann-La Roche Company Information Table 73. F. Hoffmann-La Roche Business Overview Table 74. F. Hoffmann-La Roche Arthritis Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. F. Hoffmann-La Roche Arthritis Drug Product Portfolio Table 76. F. Hoffmann-La Roche Recent Development Table 77. GSK Company Information Table 78. GSK Business Overview Table 79. GSK Arthritis Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. GSK Arthritis Drug Product Portfolio Table 81. GSK Recent Development Table 82. Pfizer Company Information Table 83. Pfizer Business Overview Table 84. Pfizer Arthritis Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Pfizer Arthritis Drug Product Portfolio Table 86. Pfizer Recent Development Table 87. Eli Lilly Company Information Table 88. Eli Lilly Business Overview Table 89. Eli Lilly Arthritis Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Eli Lilly Arthritis Drug Product Portfolio Table 91. Eli Lilly Recent Development Table 92. Novartis Company Information Table 93. Novartis Business Overview Table 94. Novartis Arthritis Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Novartis Arthritis Drug Product Portfolio Table 96. Novartis Recent Development Table 97. Johnson & Johnson Company Information Table 98. Johnson & Johnson Business Overview Table 99. Johnson & Johnson Arthritis Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Johnson & Johnson Arthritis Drug Product Portfolio Table 101. Johnson & Johnson Recent Development Table 102. Key Raw Materials Table 103. Raw Materials Key Suppliers Table 104. Arthritis Drug Distributors List Table 105. Arthritis Drug Customers List Table 106. Research Programs/Design for This Report Table 107. Authors List of This Report Table 108. Secondary Sources Table 109. Primary Sources List of Figures Figure 1. Arthritis Drug Product Image Figure 2. Global Arthritis Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Arthritis Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Arthritis Drug Sales (2021-2032) & (k units) Figure 5. Global Arthritis Drug Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Arthritis Drug Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Analgesics Image Figure 9. Biological DMARDs Image Figure 10. Corticosteroids Image Figure 11. Synthetic DMARDs Image Figure 12. NSAIDs Image Figure 13. Global Arthritis Drug Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Arthritis Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global Arthritis Drug Sales Market Share by Type (2021-2032) Figure 16. Global Arthritis Drug Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 17. Global Arthritis Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Arthritis Drug Revenue Market Share by Type (2021-2032) Figure 19. Hospital Pharmacies Image Figure 20. Drug Stores Image Figure 21. Retail Pharmacies Image Figure 22. E-Commerce Image Figure 23. Global Arthritis Drug Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 24. Global Arthritis Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 25. Global Arthritis Drug Sales Market Share by Application (2021-2032) Figure 26. Global Arthritis Drug Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 27. Global Arthritis Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 28. Global Arthritis Drug Revenue Market Share by Application (2021-2032) Figure 29. North America Arthritis Drug Sales and Growth Rate (2021-2032) & (k units) Figure 30. North America Arthritis Drug Sales Market Share by Country (2021-2032) Figure 31. U.S. Arthritis Drug Sales and Growth Rate (2021-2032) & (k units) Figure 32. Canada Arthritis Drug Sales and Growth Rate (2021-2032) & (k units) Figure 33. Mexico Arthritis Drug Sales and Growth Rate (2021-2032) & (k units) Figure 34. Europe Arthritis Drug Sales and Growth Rate (2021-2032) & (k units) Figure 35. Europe Arthritis Drug Sales Market Share by Country (2021-2032) Figure 36. Germany Arthritis Drug Sales and Growth Rate (2021-2032) & (k units) Figure 37. France Arthritis Drug Sales and Growth Rate (2021-2032) & (k units) Figure 38. U.K. Arthritis Drug Sales and Growth Rate (2021-2032) & (k units) Figure 39. Italy Arthritis Drug Sales and Growth Rate (2021-2032) & (k units) Figure 40. Netherlands Arthritis Drug Sales and Growth Rate (2021-2032) & (k units) Figure 41. Asia Pacific Arthritis Drug Sales and Growth Rate (2021-2032) & (k units) Figure 42. Asia Pacific Arthritis Drug Sales Market Share by Country (2021-2032) Figure 43. China Arthritis Drug Sales and Growth Rate (2021-2032) & (k units) Figure 44. Japan Arthritis Drug Sales and Growth Rate (2021-2032) & (k units) Figure 45. South Korea Arthritis Drug Sales and Growth Rate (2021-2032) & (k units) Figure 46. Southeast Asia Arthritis Drug Sales and Growth Rate (2021-2032) & (k units) Figure 47. India Arthritis Drug Sales and Growth Rate (2021-2032) & (k units) Figure 48. Australia Arthritis Drug Sales and Growth Rate (2021-2032) & (k units) Figure 49. South America, Middle East and Africa Arthritis Drug Sales and Growth Rate (2021-2032) & (k units) Figure 50. South America, Middle East and Africa Arthritis Drug Sales Market Share by Country (2021-2032) Figure 51. Brazil Arthritis Drug Sales and Growth Rate (2021-2032) & (k units) Figure 52. South Africa Arthritis Drug Sales and Growth Rate (2021-2032) & (k units) Figure 53. Saudi Arabia Arthritis Drug Sales and Growth Rate (2021-2032) & (k units) Figure 54. Turkey Arthritis Drug Sales and Growth Rate (2021-2032) & (k units) Figure 55. Argentina Arthritis Drug Sales and Growth Rate (2021-2032) & (k units) Figure 56. UAE Arthritis Drug Sales and Growth Rate (2021-2032) & (k units) Figure 57. Egypt Arthritis Drug Sales and Growth Rate (2021-2032) & (k units) Figure 58. Chile Arthritis Drug Sales and Growth Rate (2021-2032) & (k units) Figure 59. Global Arthritis Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Global Arthritis Drug Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 61. North America Arthritis Drug Revenue (2021-2032) & (US$ Million) Figure 62. North America Arthritis Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Europe Arthritis Drug Revenue (2021-2032) & (US$ Million) Figure 64. Europe Arthritis Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Asia-Pacific Arthritis Drug Revenue (2021-2032) & (US$ Million) Figure 66. Asia-Pacific Arthritis Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. South America, Middle East and Africa Arthritis Drug Revenue (2021-2032) & (US$ Million) Figure 68. South America, Middle East and Africa Arthritis Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 69. Arthritis Drug Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Arthritis Drug Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Analgesics
  • Biological DMARDs
  • Corticosteroids
  • Synthetic DMARDs
  • NSAIDs
Applications
  • Hospital Pharmacies
  • Drug Stores
  • Retail Pharmacies
  • E-Commerce
Companies covered
  • Celltrion
  • F. Hoffmann-La Roche
  • GSK
  • Pfizer
  • Eli Lilly
  • Novartis
  • Johnson & Johnson

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Arthritis Drug Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Arthritis Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Arthritis Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Arthritis Drug Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Arthritis Drug Market Dynamics
  1. 2.1 Arthritis Drug Industry Trends
  2. 2.2 Arthritis Drug Industry Drivers
  3. 2.3 Arthritis Drug Industry Opportunities and Challenges
  4. 2.4 Arthritis Drug Industry Restraints
3 Arthritis Drug Market by Manufacturers
  1. 3.1 Global Arthritis Drug Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Arthritis Drug Sales by Manufacturers (2021-2026)
  3. 3.3 Global Arthritis Drug Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Arthritis Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Arthritis Drug Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Arthritis Drug Manufacturers, Product Type & Application
  7. 3.7 Global Arthritis Drug Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Arthritis Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Arthritis Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Arthritis Drug Tier 1, Tier 2, and Tier 3
4 Arthritis Drug Market by Type
  1. 4.1 Arthritis Drug Type Introduction
  2. 4.1.1 Analgesics
  3. 4.1.2 Biological DMARDs
  4. 4.1.3 Corticosteroids
  5. 4.1.4 Synthetic DMARDs
  6. 4.1.5 NSAIDs
  7. 4.2 Global Arthritis Drug Sales by Type
  8. 4.2.1 Global Arthritis Drug Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Arthritis Drug Sales by Type (2021-2032)
  10. 4.2.3 Global Arthritis Drug Sales Market Share by Type (2021-2032)
  11. 4.3 Global Arthritis Drug Revenue by Type
  12. 4.3.1 Global Arthritis Drug Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Arthritis Drug Revenue by Type (2021-2032)
  14. 4.3.3 Global Arthritis Drug Revenue Market Share by Type (2021-2032)
5 Arthritis Drug Market by Application
  1. 5.1 Arthritis Drug Application Introduction
  2. 5.1.1 Hospital Pharmacies
  3. 5.1.2 Drug Stores
  4. 5.1.3 Retail Pharmacies
  5. 5.1.4 E-Commerce
  6. 5.2 Global Arthritis Drug Sales by Application
  7. 5.2.1 Global Arthritis Drug Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Arthritis Drug Sales by Application (2021-2032)
  9. 5.2.3 Global Arthritis Drug Sales Market Share by Application (2021-2032)
  10. 5.3 Global Arthritis Drug Revenue by Application
  11. 5.3.1 Global Arthritis Drug Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Arthritis Drug Revenue by Application (2021-2032)
  13. 5.3.3 Global Arthritis Drug Revenue Market Share by Application (2021-2032)
6 Global Arthritis Drug Sales by Region
  1. 6.1 Global Arthritis Drug Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Arthritis Drug Sales by Region (2021-2032)
  3. 6.2.1 Global Arthritis Drug Sales by Region (2021-2026)
  4. 6.2.2 Global Arthritis Drug Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Arthritis Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Arthritis Drug Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Arthritis Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Arthritis Drug Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Arthritis Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Arthritis Drug Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Arthritis Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Arthritis Drug Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Arthritis Drug Revenue by Region
  1. 7.1 Global Arthritis Drug Revenue by Region
  2. 7.1.1 Global Arthritis Drug Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Arthritis Drug Revenue by Region (2021-2026)
  4. 7.1.3 Global Arthritis Drug Revenue by Region (2027-2032)
  5. 7.1.4 Global Arthritis Drug Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Arthritis Drug Revenue (2021-2032)
  8. 7.2.2 North America Arthritis Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Arthritis Drug Revenue (2021-2032)
  11. 7.3.2 Europe Arthritis Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Arthritis Drug Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Arthritis Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Arthritis Drug Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Arthritis Drug Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Celltrion
  2. 8.1.1 Celltrion Company Information
  3. 8.1.2 Celltrion Business Overview
  4. 8.1.3 Celltrion Arthritis Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Celltrion Arthritis Drug Product Portfolio
  6. 8.1.5 Celltrion Recent Developments
  7. 8.2 F. Hoffmann-La Roche
  8. 8.2.1 F. Hoffmann-La Roche Company Information
  9. 8.2.2 F. Hoffmann-La Roche Business Overview
  10. 8.2.3 F. Hoffmann-La Roche Arthritis Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 F. Hoffmann-La Roche Arthritis Drug Product Portfolio
  12. 8.2.5 F. Hoffmann-La Roche Recent Developments
  13. 8.3 GSK
  14. 8.3.1 GSK Company Information
  15. 8.3.2 GSK Business Overview
  16. 8.3.3 GSK Arthritis Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 GSK Arthritis Drug Product Portfolio
  18. 8.3.5 GSK Recent Developments
  19. 8.4 Pfizer
  20. 8.4.1 Pfizer Company Information
  21. 8.4.2 Pfizer Business Overview
  22. 8.4.3 Pfizer Arthritis Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Pfizer Arthritis Drug Product Portfolio
  24. 8.4.5 Pfizer Recent Developments
  25. 8.5 Eli Lilly
  26. 8.5.1 Eli Lilly Company Information
  27. 8.5.2 Eli Lilly Business Overview
  28. 8.5.3 Eli Lilly Arthritis Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Eli Lilly Arthritis Drug Product Portfolio
  30. 8.5.5 Eli Lilly Recent Developments
  31. 8.6 Novartis
  32. 8.6.1 Novartis Company Information
  33. 8.6.2 Novartis Business Overview
  34. 8.6.3 Novartis Arthritis Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Novartis Arthritis Drug Product Portfolio
  36. 8.6.5 Novartis Recent Developments
  37. 8.7 Johnson & Johnson
  38. 8.7.1 Johnson & Johnson Company Information
  39. 8.7.2 Johnson & Johnson Business Overview
  40. 8.7.3 Johnson & Johnson Arthritis Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Johnson & Johnson Arthritis Drug Product Portfolio
  42. 8.7.5 Johnson & Johnson Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Arthritis Drug Value Chain Analysis
  2. 9.1.1 Arthritis Drug Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Arthritis Drug Production Mode & Process
  6. 9.2 Arthritis Drug Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Arthritis Drug Distributors
  9. 9.2.3 Arthritis Drug Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst